Axion BioSystems announces the acquisition of the intellectual property and assets of CytoTronics
Axion BioSystems acquires high-throughput, high-density CMOS MEA technology from CytoTronics
Axion BioSystems acquires high-throughput, high-density CMOS MEA technology from CytoTronics
New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy
Through this partnership, Axion and STEMCELL will enable scientists to examine the complex interactions between electrical cells in vitro, driving mechanistic disease research and propelling therapeutic development in neural and cardiac fields
Axion BioSystems' Maestro MEA and Z platforms now automatically link with Omni imagers, offering enhanced live-cell analysis
High-throughput organs-on-chip platforms for disease research and drug discovery in neurology and dermatology